Kim Ha Il, An Jihyun, Kim Ji Yoon, Shin Hyun Phil, Park Seo Young, Song Gi-Won, Lee Han Chu, Shim Ju Hyun
Gastroenterology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Gastroenterology and Hepatology, Hanyang University College of Medicine, Guri, Republic of Korea.
Liver Cancer. 2021 Sep 17;11(2):141-151. doi: 10.1159/000518837. eCollection 2022 Apr.
In spite of the high frequency of recurrence of hepatocellular carcinoma (HCC) after resection, little evidence exists to directly help to plan a reasonable schedule for the frequency and intensity of postoperative surveillance for recurrence.
1,918 consecutive patients with Child-Turcott-Pugh class A who had T1- or T2-staged HCCs detected by active surveillance and underwent curative resection for their tumors at 3 teaching hospitals in Korea, followed by recurrence screening at 6-monthly or shorter intervals. To set an evidence-based timetable for postoperative surveillance, we investigated the annual hazard rate of recurrence through postoperative year 10 in patients undergoing hepatectomy for HCC, and the clinical and morphological phenotypes associated with early versus late recurrence.
The estimated hazard rate for recurrence peaked during year 0-1 (21.7%), with a subsequent gradual decrease through 5 years, followed by stabilization at <7.0% until year 10, except in the case of cirrhotics, who had a rate of 10.5% during year 4-5. Multivariate time-to-recurrence analysis by recurrence period revealed that serum alpha-fetoprotein ≥200 ng/mL, larger size of tumor, tumor multiplicity, microvascular invasion, capsular invasion, and higher METAVIR fibrosis stage were significantly related to disease recurrence within 5 years after resection, while cirrhosis (METAVIR F4) alone was related to disease recurrence beyond 5 years (s < 0.05). Post-relapse overall survival was better in the latter group ( = 0.033).
Our chronological and morphological insights into recurrence after resection of primary HCCs may help implement an optimal intensity of surveillance for recurrence.
尽管肝细胞癌(HCC)切除术后复发率很高,但几乎没有证据可直接用于规划合理的术后复发监测频率和强度时间表。
1918例连续的Child-Turcott-Pugh A级患者,通过主动监测发现T1或T2期HCC,并在韩国3家教学医院接受了肿瘤根治性切除术,随后每隔6个月或更短时间进行复发筛查。为了制定基于证据的术后监测时间表,我们调查了HCC肝切除术后10年内患者的年度复发风险率,以及与早期和晚期复发相关的临床和形态学表型。
复发的估计风险率在第0 - 1年达到峰值(21.7%),随后5年逐渐下降,然后在第10年稳定在<7.0%,但肝硬化患者在第4 - 5年的复发率为10.5%。按复发期进行的多变量复发时间分析显示,血清甲胎蛋白≥200 ng/mL、肿瘤较大、肿瘤多发、微血管侵犯、包膜侵犯以及较高的METAVIR纤维化分期与切除术后5年内的疾病复发显著相关,而仅肝硬化(METAVIR F4)与5年后的疾病复发相关(P < 0.05)。后一组的复发后总生存期更好(P = 0.033)。
我们对原发性HCC切除术后复发的时间顺序和形态学见解可能有助于实施最佳的复发监测强度。